A detailed history of Livelsberger Financial Advisory transactions in Viatris Inc stock. As of the latest transaction made, Livelsberger Financial Advisory holds 514 shares of VTRS stock, worth $5,967. This represents 0.13% of its overall portfolio holdings.

Number of Shares
514
Holding current value
$5,967
% of portfolio
0.13%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$10.32 - $12.13 $5,304 - $6,234
514 New
514 $5.96 Million
Q4 2023

Mar 22, 2024

BUY
$8.77 - $10.85 $4,376 - $5,414
499 New
499 $5.4 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Livelsberger Financial Advisory Portfolio

Follow Livelsberger Financial Advisory and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Livelsberger Financial Advisory, based on Form 13F filings with the SEC.

News

Stay updated on Livelsberger Financial Advisory with notifications on news.